Alto Neuroscience, Inc.
ANRO
Jodie situation report
Alto Neuroscience, Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 21 of 21 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
- At least 14 of 21 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as CBLL begins moving with the group.
Invalidation: The live read weakens if participation falls to 7 of 21 members or fewer.
Who this business touches
The relationships behind ANRO
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AVTXAvalo Therapeutics, Inc.partnerNov 12, 2025 ▾
“License Agreement with Cerecor In May 2021, we entered into a patent and know-how license agreement, or the Cerecor Agreement, with Cerecor Inc.”
MRKMerck & Company, Inc.partnerNov 12, 2025 ▾
“License Agreement with Cerecor In May 2021, we entered into a patent and know-how license agreement, or the Cerecor Agreement, with Cerecor Inc.”
PALIPalisade Bio, Inc.partnerNov 12, 2025 ▾
“Palisade Asset Purchase Agreement In October 2021, we entered into an asset transfer agreement, or the Palisade Agreement, with Palisade Bio, Inc., or Palisade, pursuant to which we acquired all patent, know-how and other rights to ALTO-100.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ANRO is currently a Participant in the organic co-movement group Oncology and Gastrointestinal Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.